Second Sight Medical Products Inc. | Mutual Funds
Mutual Funds that own Second Sight Medical Products Inc.
Vanguard Total Stock Market Index Fund
722,783
1.08%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
327,947
0.49%
0
0%
07/31/2018
CM Advisors Fund
240,727
0.36%
0
0.76%
11/30/2017
Fidelity Spartan Extended Market Index Fund
111,337
0.17%
0
0%
07/31/2018
iShares Micro Cap ETF
71,604
0.11%
0
0.01%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
70,198
0.11%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
46,884
0.07%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
16,807
0.03%
0
0%
07/31/2018
Vanguard Balanced Index Fund
16,261
0.02%
0
0%
07/31/2018
9,217
0.01%
0
0.05%
09/05/2018
| Address |
12744 San Fernando Road
Sylmar California 91342
United States
|
|
Employees
|
- |
| Website |
http://www.secondsight.com |
| Updated |
07/08/2019 |
| Second Sight Medical Products, Inc. develops, manufactures and markets prosthetic devices. Its product the Argus II System, treats outer retinal degenerations and employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The firm's system works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina. |
